Oculis Holding AG (Nasdaq: OCS; XICE: OCS) (“Oculis” or the “Company”), a global biopharmaceutical company focused on innovations addressing ophthalmic and neuro-ophthalmic diseases with significant ...

The dollar edged up against a basket of currencies but could fall slightly if U.S. inflation data due later come in lower than expected.

KBW analyst Sanjay Sakhrani maintained a Buy rating on Visa (V – Research Report) today. The company’s shares closed yesterday at ...

Many pet owners are “humanizing” their pets, creating demand for a wider variety of products, Nestlé told Fortune exclusively ...

Explore why the USD/CHF pair may continue to rise, and what to expect in the coming months amid the Fed and SNB divergence ...

LEM HOLDING SA / Key word (s): 9 Month figures LEM faced headwinds in 9 months 2024/25 – 'Fit for Growth' program to deliver improvement in EBIT starting next year 07-Feb-2025 / 07:00 CET/CEST Release ...

Vontobel Holding on Friday reported 2.6 billion Swiss francs ($2.87 billion) in net new money for full-year 2024, falling ...

The coin will be launched exclusively at the 2025 World Money Fair. Swissmint to be guest of honour at World Money Fair On 1 July 2025, the 100th anniversary of the CHF 100 gold Vreneli will be marked ...

ZURICH, Jan 29 (Reuters) - Swiss biopharma company BioVersys said on Wednesday it had launched an initial public offering on the SIX stock exchange priced at 36 Swiss francs ($39.84) per share.

The Japanese yen rose 0.87% to 154.63 against the dollar after tightening up to 153.71, its strongest level since mid-December. The Swiss franc rose 0.50% against the greenback to $0.90155. The ...

The Japanese yen is gaining 0.8%, pushing the USD/JPY cross back below the 155 mark, while the Swiss franc is 0.5% stronger with USD/CHF at 0.9018. The U.S. dollar can often be an FX haven too ...